AVTRAvantor, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +45% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 2.3% since the previous count, up from 6.5% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AVTR is trading
Avantor, Inc. is +25% over the past year while the S&P 500 is +18%: 7.1 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +45%
vs 200-day average · a clear uptrend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- 1.1%
Below its 52-week high
Details›
- Last close2026-10-09
- $15.67
- 1 monthS&P 500 +2.7%
- +5.1%
- 1 yearS&P 500 +18%
- +25%
- 5 yearsS&P 500 +88%
- −63%
- vs 50-day average$14.56
- +7.6%
- 52-week high
- $15.85
- 52-week low
- $7.41
- Annualised volatility
- 48%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $287K
| Year | Return |
|---|---|
| 2026 (year to date) | +37% |
| 2025 | −46% |
| 2024 | −7.7% |
| 2023 | +8.3% |
| 2022 | −50% |
| 2021 | +50% |
| 2020 | +55% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 5 of 7 | +1.5% |
| Feb | 7 | 2 of 7 | −8.6% |
| Mar | 7 | 2 of 7 | −6.5% |
| Apr | 7 | 3 of 7 | +1.4% |
| May | 7 | 5 of 7 | +3.9% |
| Jun | 8 | 5 of 8 | +1.5% |
| Jul | 8 | 5 of 8 | +8.9% |
| Aug | 8 | 5 of 8 | +1.4% |
| Sep | 8 | 3 of 8 | −5.0% |
| Oct | 8 | 3 of 8 | −3.8% |
| Nov | 7 | 4 of 7 | +8.7% |
| Dec | 7 | 5 of 7 | +2.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #12 of 21 by RyuScore